BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23349954)

  • 41. A two-center review of bacteremia in the community hospital.
    Haddy RI; Klimberg S; Epting RJ
    J Fam Pract; 1987 Mar; 24(3):253-9. PubMed ID: 3546587
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidemiology and clinical features of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae.
    Lee JA; Kang CI; Joo EJ; Ha YE; Kang SJ; Park SY; Chung DR; Peck KR; Ko KS; Lee NY; Song JH
    Microb Drug Resist; 2011 Jun; 17(2):267-73. PubMed ID: 21388296
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extended-spectrum beta-lactamase-producing phenotype signifies a poor prognosis for patients with cefpodoxime-resistant Escherichia coli or Klebsiella pneumoniae bacteremia.
    Lee CI; Lee NY; Yan JJ; Lee HC; Ko NY; Chang CM; Wu CJ; Chen PL; Wang LR; Ko WC
    J Microbiol Immunol Infect; 2009 Aug; 42(4):303-9. PubMed ID: 19949753
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bacterial bloodstream infections in a tertiary infectious diseases hospital in Northern Vietnam: aetiology, drug resistance, and treatment outcome.
    Dat VQ; Vu HN; Nguyen The H; Nguyen HT; Hoang LB; Vu Tien Viet D; Bui CL; Van Nguyen K; Nguyen TV; Trinh DT; Torre A; van Doorn HR; Nadjm B; Wertheim HFL
    BMC Infect Dis; 2017 Jul; 17(1):493. PubMed ID: 28701159
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Risk factors and prognosis in 31 patients with extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bloodstream infection].
    Chen YH; Yao WZ; Wu R; Zhou QT; Liu ZY; Zhang XW
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov; 31(11):815-9. PubMed ID: 19080534
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Frequency of Blood Culture Isolates and their Antibiogram in a Teaching hospital.
    Shrestha S; Amatya R; Shrestha RK; Shrestha R
    JNMA J Nepal Med Assoc; 2014; 52(193):692-6. PubMed ID: 26905550
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extended spectrum beta-lactamases in Escherichia coli & Klebsiella pneumoniae & associated risk factors.
    Goyal A; Prasad KN; Prasad A; Gupta S; Ghoshal U; Ayyagari A
    Indian J Med Res; 2009 Jun; 129(6):695-700. PubMed ID: 19692752
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Common hydrotherapy practices and the prevalence of burn wound bacterial colonisation at the University Teaching Hospital in Lusaka, Zambia.
    Ziwa M; Jovic G; Ngwisha CLT; Molnar JA; Kwenda G; Samutela M; Mulowa M; Kalumbi MM
    Burns; 2019 Jun; 45(4):983-989. PubMed ID: 30595542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increasing incidence of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in Belgian hospitals.
    De Laveleye M; Huang TD; Bogaerts P; Berhin C; Bauraing C; Sacré P; Noel A; Glupczynski Y;
    Eur J Clin Microbiol Infect Dis; 2017 Jan; 36(1):139-146. PubMed ID: 27639859
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk factors for and outcomes of healthcare-associated infection due to extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae in Thailand.
    Apisarnthanarak A; Kiratisin P; Saifon P; Kitphati R; Dejsirilert S; Mundy LM
    Infect Control Hosp Epidemiol; 2007 Jul; 28(7):873-6. PubMed ID: 17564993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Community-acquired bacteremia at a teaching versus a nonteaching hospital: impact of acute severity of illness on 30-day mortality.
    Mylotte JM; Kahler L; McCann C
    Am J Infect Control; 2001 Feb; 29(1):13-9. PubMed ID: 11172313
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).
    De Angelis G; Fiori B; Menchinelli G; D'Inzeo T; Liotti FM; Morandotti GA; Sanguinetti M; Posteraro B; Spanu T
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1627-1636. PubMed ID: 29948360
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children.
    Zaoutis TE; Goyal M; Chu JH; Coffin SE; Bell LM; Nachamkin I; McGowan KL; Bilker WB; Lautenbach E
    Pediatrics; 2005 Apr; 115(4):942-9. PubMed ID: 15805368
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High prevalence of ESBL-producing Escherichia coli and Klebsiella pneumoniae in community-onset bloodstream infections in China.
    Quan J; Zhao D; Liu L; Chen Y; Zhou J; Jiang Y; Du X; Zhou Z; Akova M; Yu Y
    J Antimicrob Chemother; 2017 Jan; 72(1):273-280. PubMed ID: 27624571
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intra-Abdominal Infections: Prevalence and Risk Factors of ESBLs Infections.
    Boontham P; Soontomrak R
    J Med Assoc Thai; 2015 Nov; 98(11):1097-103. PubMed ID: 26817180
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of appropriateness of empiric therapy on outcomes in community-onset bacteremia by extended-spectrum-β-lactamase producing Escherichia coli and Klebisella pneumoniae definitively treated with carbapenems.
    Joo EJ; Park DA; Lee NR; Moon SY; Choi JK; Ko JH; Peck KR
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2093-2100. PubMed ID: 28643188
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Klebsiella pneumoniae related community-acquired acute lower respiratory infections in Cambodia: clinical characteristics and treatment.
    Rammaert B; Goyet S; Beauté J; Hem S; Te V; Try PL; Mayaud C; Borand L; Buchy P; Guillard B; Vong S
    BMC Infect Dis; 2012 Jan; 12():3. PubMed ID: 22233322
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence and patient related factors associated with Extended-Spectrum Beta-Lactamase producing Escherichia coli and Klebsiella pneumoniae carriage and infection among pediatric patients in Tanzania.
    Letara N; Ngocho JS; Karami N; Msuya SE; Nyombi B; Kassam NA; Skovbjerg S; Åhren C; Philemon R; Mmbaga BT
    Sci Rep; 2021 Nov; 11(1):22759. PubMed ID: 34815472
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae--a case-control study in a low prevalence country.
    Søraas A; Sundsfjord A; Sandven I; Brunborg C; Jenum PA
    PLoS One; 2013; 8(7):e69581. PubMed ID: 23936052
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of high mortality with extended-spectrum β-lactamase (ESBL) positive cultures in community acquired infections.
    Ray S; Anand D; Purwar S; Samanta A; Upadhye KV; Gupta P; Dhar D
    J Crit Care; 2018 Apr; 44():255-260. PubMed ID: 29220754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.